| scholarly article | Q13442814 |
| P50 | author | Annemiek A van der Eijk | Q90329635 |
| Suzan D Pas | Q56871934 | ||
| P2093 | author name string | Harry R Dalton | |
| Richie G Madden | |||
| P2860 | cites work | Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure | Q27646563 |
| Structural basis for the neutralization and genotype specificity of hepatitis E virus | Q27666250 | ||
| Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b | Q63880169 | ||
| Prevalence of hepatitis E virus infection in liver transplant recipients | Q63880173 | ||
| A community prevalence study of antibodies to hepatitis A and E in inner-city London | Q71562465 | ||
| Low B-cell and monocyte counts on day 80 are associated with high infection rates between days 100 and 365 after allogeneic marrow transplantation | Q73119366 | ||
| Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation | Q82697539 | ||
| First case report of an acute genotype 3 hepatitis E infected pregnant woman living in South-Eastern France | Q83451570 | ||
| Test performance characteristics of Anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates | Q85422096 | ||
| Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease | Q45393741 | ||
| Hepatitis E virus and chronic hepatitis in organ-transplant recipients | Q45397012 | ||
| Evaluation of anti-hepatitis E virus (HEV) immunoglobulin A in a serological screening for HEV infection | Q45399246 | ||
| Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma. | Q45407207 | ||
| Hepatitis E virus: A new entity | Q46298826 | ||
| Chronic hepatitis E with cirrhosis in a kidney-transplant recipient | Q46743789 | ||
| Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin? | Q50557345 | ||
| Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts. | Q50619741 | ||
| Hepatitis E | Q56656388 | ||
| Hepatitis E in an HIV-infected patient | Q57241719 | ||
| Hepatitis E in The Netherlands: imported and endemic | Q57924344 | ||
| 148 LOCALLY ACQUIRED HEPATITIS E. GEOGRAPHICAL CLUSTERING AND ENVIRONMENTAL FACTORS: A NESTED CASE CONTROL STUDY | Q57943882 | ||
| Chronic hepatitis E in hematopoietic stem cell transplant patients in a low-endemic country? | Q59240797 | ||
| Chronic hepatitis E virus infection in liver transplant recipients | Q37126185 | ||
| Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: delineation of an additional group of positive-strand RNA plant and animal viruses | Q37186191 | ||
| Hepatitis E: an emerging infection in developed countries. | Q37320904 | ||
| Host risk factors and autochthonous hepatitis E infection | Q37937407 | ||
| Characteristics of Epstein-Barr virus hepatitis among patients with jaundice or acute hepatitis. | Q38007217 | ||
| Hepatitis E virus: neutralizing sites, diagnosis, and protective immunity | Q38014371 | ||
| Hepatitis E: clinical presentation in disease-endemic areas and diagnosis | Q38096969 | ||
| Hepatitis E virus infection in immunosuppressed patients: natural history and therapy | Q38096973 | ||
| Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation | Q39164181 | ||
| A PSAP motif in the ORF3 protein of hepatitis E virus is necessary for virion release from infected cells. | Q39633451 | ||
| Heparan sulfate proteoglycans are required for cellular binding of the hepatitis E virus ORF2 capsid protein and for viral infection | Q39790232 | ||
| Hepatitis E virus genotyping based on full-length genome and partial genomic regions | Q40351420 | ||
| Hepatitis E virus in pork food chain, United Kingdom, 2009-2010. | Q41910835 | ||
| Good performance of immunoglobulin M assays in diagnosing genotype 3 hepatitis E virus infections | Q42016304 | ||
| Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients | Q42256720 | ||
| The clinical course of hepatitis E virus infection in patients of a tertiary Dutch hospital over a 5-year period | Q42268042 | ||
| Hepatitis E virus in England and Wales: indigenous infection is associated with the consumption of processed pork products | Q42268101 | ||
| Role of hepatitis E virus antigen in confirming active viral replication in patients with acute viral hepatitis E infection | Q42275297 | ||
| Comparison of real-time RT-PCR assays for hepatitis E virus RNA detection | Q42281426 | ||
| Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation | Q42288848 | ||
| Mutational analysis of essential interactions involved in the assembly of hepatitis E virus capsid. | Q42470891 | ||
| Detection and molecular characterization of hepatitis E virus in clinical, environmental and putative animal sources | Q42661332 | ||
| A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. | Q42663129 | ||
| Analysing complete genome sequence of swine hepatitis E virus (HEV), strain CHN-XJ-SW13 isolated from Xinjiang, China: putative host range, and disease severity determinants in HEV. | Q42688832 | ||
| Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection | Q42938081 | ||
| Hepatitis E virus genotype 3 in shellfish, United Kingdom | Q43056858 | ||
| Transfusion-associated hepatitis E, France | Q43071303 | ||
| Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation | Q43166681 | ||
| Unexpected high prevalence of IgG-antibodies to hepatitis E virus in Swedish pig farmers and controls | Q43219497 | ||
| Transfusion-transmitted hepatitis E in a 'nonhyperendemic' country. | Q43220367 | ||
| Genetic variability of HEV isolates: inconsistencies of current classification. | Q43683925 | ||
| Identification and characterization of the neutralization epitope(s) of the hepatitis E virus | Q43767391 | ||
| Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience | Q43974173 | ||
| Treatment of chronic hepatitis E in a patient with HIV infection. | Q44768705 | ||
| Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants | Q44790182 | ||
| Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. | Q44905821 | ||
| Persistent carriage of hepatitis E virus in patients with HIV infection. | Q45019291 | ||
| Low risk of hepatitis E virus reactivation after haematopoietic stem cell transplantation | Q45029562 | ||
| The incidence of hepatitis E virus infection in the general population of the USA | Q45185642 | ||
| Hepatitis E virus in Scottish blood donors | Q45350768 | ||
| Clinical implications of chronic hepatitis E virus infection in heart transplant recipients | Q45353378 | ||
| Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States | Q45360617 | ||
| Detection of hepatitis E virus RNA in plasma mini-pools from blood donors in England. | Q45362903 | ||
| Is there evidence of recent hepatitis E virus infection in English and North Welsh blood donors? | Q45368321 | ||
| Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France | Q45373867 | ||
| Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances | Q45374976 | ||
| The ORF3 protein of hepatitis E virus binds to Src homology 3 domains and activates MAPK. | Q30167985 | ||
| Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome | Q33415661 | ||
| A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries | Q33545709 | ||
| Profile of acute infectious markers in sporadic hepatitis E. | Q33735801 | ||
| Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis | Q33746244 | ||
| Hepatitis E outbreak on cruise ship. | Q33800746 | ||
| Insufficient recovery of thymopoiesis predicts for opportunistic infections in allogeneic hematopoietic stem cell transplant recipients | Q34000647 | ||
| High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France | Q34008923 | ||
| Hepatitis E virus and neurologic disorders | Q34025611 | ||
| Thermal inactivation of infectious hepatitis E virus in experimentally contaminated food | Q34031991 | ||
| A novel member of the family Hepeviridae from cutthroat trout (Oncorhynchus clarkii). | Q34175127 | ||
| Transmission dynamics of hepatitis E virus in pigs: estimation from field data and effect of vaccination | Q34291747 | ||
| A novel virus in swine is closely related to the human hepatitis E virus | Q34437217 | ||
| A bicistronic subgenomic mRNA encodes both the ORF2 and ORF3 proteins of hepatitis E virus | Q34651218 | ||
| An analysis of the benefit of using HEV genotype 3 antigens in detecting anti-HEV IgG in a European population | Q34717939 | ||
| Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance | Q35067078 | ||
| Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity | Q35783632 | ||
| Hepatitis E virus antibodies in blood donors, France | Q35849075 | ||
| Hepatitis E virus in rats, Los Angeles, California, USA. | Q35849103 | ||
| An assessment of hepatitis E virus (HEV) in US blood donors and recipients: no detectable HEV RNA in 1939 donors tested and no evidence for HEV transmission to 362 prospectively followed recipients | Q35972883 | ||
| Hepatitis E virus infection among solid organ transplant recipients, the Netherlands | Q35979542 | ||
| Thymopoiesis following allogeneic stem cell transplantation: new possibilities for improvement | Q35986680 | ||
| Autochthonous infections with hepatitis E virus genotype 4, France. | Q36148077 | ||
| Hepatitis E virus strains in rabbits and evidence of a closely related strain in humans, France | Q36148094 | ||
| Novel approach for detection of hepatitis E virus infection in German blood donors | Q36171437 | ||
| Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis | Q36263223 | ||
| Hepatitis E virus genotype 4 outbreak, Italy, 2011. | Q36570895 | ||
| Laboratory-based surveillance for hepatitis E virus infection, United States, 2005-2012. | Q36584546 | ||
| The hepatitis E virus open reading frame 3 protein activates ERK through binding and inhibition of the MAPK phosphatase | Q36739811 | ||
| The hepatitis E virus ORF3 protein modulates epidermal growth factor receptor trafficking, STAT3 translocation, and the acute-phase response | Q36747760 | ||
| World Health Organization International Standard to harmonize assays for detection of hepatitis E virus RNA. | Q36825509 | ||
| Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury | Q36845686 | ||
| The role of hepatitis E virus testing in drug-induced liver injury. | Q36938489 | ||
| Performance of two commercial assays for detecting hepatitis E virus RNA in acute or chronic infections | Q37026483 | ||
| P433 | issue | 4 | |
| P921 | main subject | hepatitis E | Q326643 |
| hepatitis E virus | Q5731737 | ||
| P304 | page(s) | 399 | |
| P577 | publication date | 2014-04-01 | |
| P1433 | published in | Current infectious disease reports | Q26842136 |
| P1476 | title | Hepatitis e virus: current concepts and future perspectives | |
| P478 | volume | 16 |
| Q55100910 | Chronic Genotype 3 Hepatitis E in Pregnant Woman Receiving Infliximab and Azathioprine. |
| Q92129929 | Chronic Hepatitis E is associated with cholangitis |
| Q39348795 | Hepatitis E in Norway: seroprevalence in humans and swine |
| Q42206956 | Hepatitis E in patients with hepatic disorders and HIV-infected patients in Croatia: is one diagnostic method enough for hepatitis E diagnosis? |
| Q41495298 | Hepatitis E virus infection presenting with paraesthesia |
| Q37444294 | Hepatitis E virus: Western Cape, South Africa |
| Q34257095 | Hepatitis e infection in a renal transplant recipient |
| Q57002609 | Ingesting Self-Grown Produce and Seropositivity for Hepatitis E in the United States |
| Q39625935 | Low transfusion transmission of hepatitis E among 25,637 single-donation, nucleic acid-tested blood donors |
| Q42201538 | Novel molecular alterations in the ORF 2 capsid gene of hepatitis E virus in patients with acute liver failure in North India |
| Q34575800 | Seroepidemiology of hepatitis e virus infection in mennonites in Mexico |
| Q54214343 | Seroprevalence of Hepatitis E Virus in Roma Settlements: A Comparison with the General Population in Slovakia. |
Search more.